speb/financial-data huggingface dataset:
BINT.OL cash_flow (annual, 2025-12-31) — Sale Of Investment Properties: 0.00
BINT.OL balance_sheet (annual, 2025-12-31) — Share Issued: 939664.00
BINT.OL balance_sheet (quarterly, 2025-12-31) — Share Issued: 939664.00
BINT.OL income_statement (annual, 2025-12-31) — Special Income Charges: -91800000.00
BINT.OL balance_sheet (annual, 2025-12-31) — Stockholders Equity: 3299600000.00
BINT.OL balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 3299600000.00
BINT.OL balance_sheet (annual, 2025-12-31) — Tangible Book Value: -766500000.00
BINT.OL balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -766500000.00
BINT.OL income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -1959101.77
BINT.OL income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BINT.OL income_statement (annual, 2025-12-31) — Tax Provision: -13400000.00
BINT.OL income_statement (quarterly, 2025-12-31) — Tax Provision: 6700000.00
BINT.OL income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.02
BINT.OL income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.22
BINT.OL balance_sheet (annual, 2025-12-31) — Taxes Receivable: 15000000.00
BINT.OL balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 15000000.00
BINT.OL cash_flow (annual, 2025-12-31) — Taxes Refund Paid: 0.00
BINT.OL cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -7900000.00
BINT.OL balance_sheet (annual, 2025-12-31) — Total Assets: 16598200000.00
BINT.OL balance_sheet (quarterly, 2025-12-31) — Total Assets: 16598200000.00
BINT.OL balance_sheet (annual, 2025-12-31) — Total Capitalization: 7949600000.00
BINT.OL balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 7949600000.00
BINT.OL balance_sheet (annual, 2025-12-31) — Total Debt: 8139700000.00
BINT.OL balance_sheet (quarterly, 2025-12-31) — Total Debt: 8139700000.00
BINT.OL balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 6063200000.00
BINT.OL balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 6063200000.00
BINT.OL income_statement (annual, 2025-12-31) — Total Expenses: 9651700000.00
BINT.OL income_statement (quarterly, 2025-12-31) — Total Expenses: 2431000000.00
BINT.OL balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 10535000000.00
BINT.OL balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 10535000000.00
BINT.OL balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 13384900000.00
BINT.OL balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 13384900000.00
BINT.OL balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 8031200000.00
BINT.OL balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 8031200000.00
BINT.OL income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -19600000.00
BINT.OL income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -35500000.00
BINT.OL balance_sheet (annual, 2025-12-31) — Total Tax Payable: 28700000.00
BINT.OL balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 28700000.00
BINT.OL income_statement (annual, 2025-12-31) — Total Unusual Items: -91800000.00
BINT.OL income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -91800000.00
BINT.OL balance_sheet (annual, 2025-12-31) — Treasury Stock: 800000.00
BINT.OL balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 800000.00
BINT.OL balance_sheet (annual, 2025-12-31) — Working Capital: 709500000.00
BINT.OL balance_sheet (quarterly, 2025-12-31) — Working Capital: 709500000.00
BINT.OL income_statement (annual, 2025-12-31) — Write Off: 91800000.00
BINT.OL income_statement (quarterly, 2026-03-31) — +Operating Expense: 1431500000.00
BINT.OL income_statement (quarterly, 2026-03-31) — +Total Revenue: 2454600000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 763600000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 824700000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 0.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 12000000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Basic Average Shares: 101996569.00
BINT.OL income_statement (quarterly, 2026-03-31) — Basic EPS: -1.04
BINT.OL cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 854500000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -75300000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 3139900000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Capital Stock: 13900000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 747300000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 751500000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -59100000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Changes In Cash: -144200000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Common Stock: 13900000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 3142600000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
BINT.OL income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1029500000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Current Assets: 3315900000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 405800000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Current Debt: 287000000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 692800000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 2692000000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 220100000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 220100000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 101996569.00
BINT.OL income_statement (quarterly, 2026-03-31) — Diluted EPS: -1.04
BINT.OL income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -106100000.00
BINT.OL income_statement (quarterly, 2026-03-31) — EBIT: 148200000.00
BINT.OL income_statement (quarterly, 2026-03-31) — EBITDA: 368300000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 36900000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — End Cash Position: 747300000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -176600000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 50800000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Goodwill: 2551900000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 3876600000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Gross PPE: 5039800000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Gross Profit: 1425100000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Interest Expense: 263100000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 263100000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Interest Income: 137200000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 137200000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Inventory: 1056700000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Invested Capital: 7955200000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -93700000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Investment Properties: 379900000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 12000000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: 2982300000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 2734100000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 4525600000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 7259700000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -17200000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 2982300000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 15800000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 2259300000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Minority Interest: 2626800000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Minority Interests: 53600000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 10100000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Net Debt: 4065300000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Net Income: -88500000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -106100000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -111500000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: -30600000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -88500000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -57900000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 33500000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -142100000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Net Interest Income: -125900000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -17200000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -17200000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -125900000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -159400000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -28500000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Net PPE: 5039800000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -75300000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -734000000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 227600000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 505600000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 368300000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Normalized Income: -57900000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 126100000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Operating Income: -6400000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Operating Revenue: 2454600000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 939664.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 100000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1167600000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 3128700000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1324700000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 347700000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 621100000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Other Receivables: 683000000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 4200000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 17600000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Payables: 785200000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 0.00
BINT.OL income_statement (quarterly, 2026-03-31) — Pretax Income: -114900000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Properties: 2780500000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -75300000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1029500000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 220100000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -17200000.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
BINT.OL cash_flow (quarterly, 2026-03-31) — Sale Of Business: 10100000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Share Issued: 939664.00
BINT.OL income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 3142600000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -734000000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BINT.OL income_statement (quarterly, 2026-03-31) — Tax Provision: -3400000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.03
BINT.OL cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: -27300000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Total Assets: 16242500000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 7668200000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Total Debt: 7952500000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 5769400000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Total Expenses: 2461000000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 10473100000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 12926600000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 7781100000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 33500000.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 21600000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
BINT.OL income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BINT.OL balance_sheet (quarterly, 2026-03-31) — Working Capital: 623900000.00
BINT.OL income_statement (quarterly, 2026-03-31) — Write Off: 0.00
BIO balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 50852000.00
BIO balance_sheet (annual, 2021-12-31) — Current Deferred Revenue: 50852000.00
BIO income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 0.00
BIO balance_sheet (annual, 2021-12-31) — Income Tax Payable: 10319000.00
BIO cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
BIO cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
BIO cash_flow (annual, 2021-12-31) — Net Other Investing Changes: -453440000.00
BIO balance_sheet (annual, 2021-12-31) — Other Inventories: 39000.00
BIO balance_sheet (annual, 2021-12-31) — Restricted Cash: 5560000.00
BIO income_statement (annual, 2022-12-31) — +Operating Expense: 1092200000.00
BIO income_statement (annual, 2022-12-31) — +Total Revenue: 2802200000.00
BIO balance_sheet (annual, 2022-12-31) — Accounts Payable: 135041000.00
BIO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 494645000.00
BIO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1009400000.00
BIO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 447454000.00
BIO balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -15029000.00
BIO cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 11900000.00
BIO income_statement (annual, 2022-12-31) — Basic Average Shares: 29785000.00
BIO income_statement (annual, 2022-12-31) — Basic EPS: -121.79
BIO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 471100000.00
BIO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 393600000.00
BIO cash_flow (annual, 2022-12-31) — Capital Expenditure: -114300000.00
BIO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 189933000.00
BIO balance_sheet (annual, 2022-12-31) — Capital Stock: 3000.00
BIO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 434215000.00
BIO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1790672000.00
BIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 973600000.00
BIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1207600000.00
BIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 194400000.00
BIO cash_flow (annual, 2022-12-31) — Change In Account Payable: -94200000.00
BIO cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: -1200000.00
BIO cash_flow (annual, 2022-12-31) — Change In Inventory: -158800000.00
BIO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -32400000.00
BIO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 5600000.00
BIO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -1241600000.00
BIO cash_flow (annual, 2022-12-31) — Change In Payable: -95400000.00
BIO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -95400000.00
BIO cash_flow (annual, 2022-12-31) — Change In Receivables: -87400000.00
BIO cash_flow (annual, 2022-12-31) — Change In Tax Payable: -1200000.00
BIO cash_flow (annual, 2022-12-31) — Change In Working Capital: -1610000000.00
BIO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -87400000.00
BIO cash_flow (annual, 2022-12-31) — Changes In Cash: -39600000.00
BIO balance_sheet (annual, 2022-12-31) — Common Stock: 3000.00
BIO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 9615252000.00
BIO cash_flow (annual, 2022-12-31) — Common Stock Payments: -215700000.00
BIO income_statement (annual, 2022-12-31) — Cost Of Revenue: 1234900000.00
BIO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 194790000.00
BIO balance_sheet (annual, 2022-12-31) — Current Assets: 3157976000.00
BIO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 36336000.00
BIO balance_sheet (annual, 2022-12-31) — Current Debt: 465000.00
BIO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 36801000.00
BIO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 52211000.00
BIO balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 52211000.00
BIO balance_sheet (annual, 2022-12-31) — Current Liabilities: 568708000.00
BIO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 137300000.00
BIO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 137300000.00
BIO income_statement (annual, 2022-12-31) — Diluted Average Shares: 29785000.00
BIO income_statement (annual, 2022-12-31) — Diluted EPS: -121.79
BIO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -3627500000.00
BIO income_statement (annual, 2022-12-31) — EBIT: -4666100000.00
BIO income_statement (annual, 2022-12-31) — EBITDA: -4528800000.00
BIO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 3000000.00
BIO cash_flow (annual, 2022-12-31) — End Cash Position: 434500000.00
BIO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 973600000.00
BIO balance_sheet (annual, 2022-12-31) — Finished Goods: 269600000.00
BIO cash_flow (annual, 2022-12-31) — Free Cash Flow: 80100000.00
BIO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -1400000.00
BIO income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 1400000.00
BIO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -5191100000.00
BIO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -466822000.00
BIO balance_sheet (annual, 2022-12-31) — Goodwill: 406500000.00
BIO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 738600000.00
BIO balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 509674000.00
BIO balance_sheet (annual, 2022-12-31) — Gross PPE: 1688952000.00
BIO income_statement (annual, 2022-12-31) — Gross Profit: 1567300000.00
BIO balance_sheet (annual, 2022-12-31) — Income Tax Payable: 11929000.00
BIO income_statement (annual, 2022-12-31) — Interest Expense: 38100000.00
BIO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 38100000.00
BIO income_statement (annual, 2022-12-31) — Interest Income: 58100000.00
BIO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 58100000.00
BIO balance_sheet (annual, 2022-12-31) — Inventory: 719316000.00
BIO balance_sheet (annual, 2022-12-31) — Invested Capital: 10813417000.00
BIO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1207600000.00
BIO balance_sheet (annual, 2022-12-31) — Investments And Advances: 8830892000.00
BIO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 1186200000.00
BIO balance_sheet (annual, 2022-12-31) — Land And Improvements: 27800000.00
BIO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 153597000.00
BIO balance_sheet (annual, 2022-12-31) — Long Term Debt: 1197700000.00
BIO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1351297000.00
BIO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 1186200000.00
BIO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -500000.00
BIO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -99300000.00
BIO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -215700000.00
BIO balance_sheet (annual, 2022-12-31) — Net Debt: 763950000.00
BIO income_statement (annual, 2022-12-31) — Net Income: -3627500000.00
BIO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -3627500000.00
BIO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -3627500000.00
BIO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -3627500000.00
BIO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -3627500000.00
BIO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -3627500000.00
BIO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -3627500000.00
BIO cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -1500000.00
BIO income_statement (annual, 2022-12-31) — Net Interest Income: 20000000.00
BIO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -994200000.00
BIO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 1185700000.00
BIO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 1185700000.00
BIO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 20000000.00
BIO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -14000000.00
BIO balance_sheet (annual, 2022-12-31) — Net PPE: 679552000.00
BIO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -112600000.00
BIO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 8876652000.00
BIO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 1770481000.00
BIO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 1770481000.00
BIO income_statement (annual, 2022-12-31) — Normalized EBITDA: 672800000.00
BIO income_statement (annual, 2022-12-31) — Normalized Income: 382933600.00
BIO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 194400000.00
BIO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -1400000.00
BIO income_statement (annual, 2022-12-31) — Operating Income: 475100000.00
BIO income_statement (annual, 2022-12-31) — Operating Revenue: 2802200000.00
BIO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 29595713.00
BIO balance_sheet (annual, 2022-12-31) — Other Current Assets: 23604000.00
BIO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 465000.00
BIO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 169648000.00
BIO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -466822000.00
BIO income_statement (annual, 2022-12-31) — Other Income Expense: -5199300000.00
BIO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 332100000.00
BIO balance_sheet (annual, 2022-12-31) — Other Inventories: 16000.00
BIO balance_sheet (annual, 2022-12-31) — Other Investments: 8830892000.00
BIO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 22100000.00
BIO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 94599000.00
BIO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 195928000.00
BIO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 2300000.00
BIO income_statement (annual, 2022-12-31) — Other Operating Expenses: 7500000.00
BIO balance_sheet (annual, 2022-12-31) — Other Properties: 1267552000.00
BIO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 1356457000.00
BIO balance_sheet (annual, 2022-12-31) — Payables: 167469000.00
BIO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 362259000.00
BIO balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
BIO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 124179000.00
BIO income_statement (annual, 2022-12-31) — Pretax Income: -4704200000.00
BIO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 17600000.00
BIO balance_sheet (annual, 2022-12-31) — Properties: 0.00
BIO income_statement (annual, 2022-12-31) — Provision For Doubtful Accounts: 7500000.00
BIO cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 7500000.00
BIO cash_flow (annual, 2022-12-31) — Purchase Of Business: -100700000.00
BIO cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -1500000.00
BIO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -2060200000.00
BIO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -112800000.00
BIO balance_sheet (annual, 2022-12-31) — Raw Materials: 228800000.00
BIO balance_sheet (annual, 2022-12-31) — Receivables: 494645000.00
BIO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1234900000.00
BIO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 137300000.00
BIO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -500000.00
BIO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -215700000.00
BIO income_statement (annual, 2022-12-31) — Research And Development: 256900000.00
BIO balance_sheet (annual, 2022-12-31) — Restricted Cash: 5560000.00
BIO balance_sheet (annual, 2022-12-31) — Retained Earnings: 9898203000.00
BIO cash_flow (annual, 2022-12-31) — Sale Of Business: 1400000.00
BIO cash_flow (annual, 2022-12-31) — Sale Of Investment: 1066000000.00
BIO cash_flow (annual, 2022-12-31) — Sale Of PPE: 200000.00
BIO income_statement (annual, 2022-12-31) — Selling General And Administration: 827800000.00
BIO balance_sheet (annual, 2022-12-31) — Share Issued: 30236205.00
BIO income_statement (annual, 2022-12-31) — Special Income Charges: -10500000.00
BIO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 60900000.00
BIO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 9615252000.00
BIO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 8876652000.00
BIO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -1191166400.00
BIO income_statement (annual, 2022-12-31) — Tax Provision: -1076700000.00
BIO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.23
BIO balance_sheet (annual, 2022-12-31) — Total Assets: 13501666000.00
BIO balance_sheet (annual, 2022-12-31) — Total Capitalization: 10812952000.00
BIO balance_sheet (annual, 2022-12-31) — Total Debt: 1388098000.00
BIO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 9615252000.00
BIO income_statement (annual, 2022-12-31) — Total Expenses: 2327100000.00
BIO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3886414000.00
BIO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 10343643000.00
BIO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 3317706000.00
BIO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 482600000.00
BIO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 32428000.00
BIO income_statement (annual, 2022-12-31) — Total Unusual Items: -5201600000.00
BIO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -5201600000.00
BIO balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 640492.00
BIO balance_sheet (annual, 2022-12-31) — Treasury Stock: 263586000.00
BIO cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 5193600000.00
BIO balance_sheet (annual, 2022-12-31) — Work In Process: 220900000.00
BIO balance_sheet (annual, 2022-12-31) — Working Capital: 2589268000.00
BIO income_statement (annual, 2022-12-31) — Write Off: 11900000.00
BIO income_statement (annual, 2023-12-31) — +Operating Expense: 1089100000.00
BIO income_statement (annual, 2023-12-31) — +Total Revenue: 2671200000.00
BIO balance_sheet (annual, 2023-12-31) — Accounts Payable: 144600000.00
BIO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 489000000.00
BIO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1066700000.00
BIO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 449100000.00
BIO balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -14900000.00
BIO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
BIO income_statement (annual, 2023-12-31) — Basic Average Shares: 29209000.00
BIO income_statement (annual, 2023-12-31) — Basic EPS: -21.82
BIO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 434500000.00
BIO balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 419800000.00
BIO cash_flow (annual, 2023-12-31) — Capital Expenditure: -156700000.00
BIO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 205900000.00
BIO balance_sheet (annual, 2023-12-31) — Capital Stock: 0.00
BIO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 403800000.00
BIO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 1607100000.00
BIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -425600000.00
BIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 20200000.00
BIO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 374900000.00
BIO cash_flow (annual, 2023-12-31) — Change In Account Payable: -51800000.00
BIO cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: -21300000.00
BIO cash_flow (annual, 2023-12-31) — Change In Inventory: -46300000.00
BIO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 1900000.00
BIO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -4100000.00
BIO cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -322600000.00
BIO cash_flow (annual, 2023-12-31) — Change In Payable: -73100000.00
BIO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -73100000.00
BIO cash_flow (annual, 2023-12-31) — Change In Receivables: 11400000.00
BIO cash_flow (annual, 2023-12-31) — Change In Tax Payable: -21300000.00
BIO cash_flow (annual, 2023-12-31) — Change In Working Capital: -432800000.00
BIO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 11400000.00
BIO cash_flow (annual, 2023-12-31) — Changes In Cash: -30500000.00
BIO balance_sheet (annual, 2023-12-31) — Common Stock: 0.00
BIO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 8741200000.00
BIO cash_flow (annual, 2023-12-31) — Common Stock Payments: -428700000.00
BIO income_statement (annual, 2023-12-31) — Cost Of Revenue: 1244300000.00
BIO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 139900000.00
BIO balance_sheet (annual, 2023-12-31) — Current Assets: 3048300000.00
BIO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 40400000.00
BIO balance_sheet (annual, 2023-12-31) — Current Debt: 500000.00
BIO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 40900000.00
BIO balance_sheet (annual, 2023-12-31) — Current Liabilities: 522800000.00
BIO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 145900000.00
BIO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 145900000.00
BIO income_statement (annual, 2023-12-31) — Diluted Average Shares: 29209000.00
BIO income_statement (annual, 2023-12-31) — Diluted EPS: -21.82
BIO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -637300000.00
BIO income_statement (annual, 2023-12-31) — EBIT: -800700000.00
BIO income_statement (annual, 2023-12-31) — EBITDA: -654800000.00
BIO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 400000.00
BIO cash_flow (annual, 2023-12-31) — End Cash Position: 404400000.00
BIO cash_flow (annual, 2023-12-31) — Financing Cash Flow: -425600000.00
BIO balance_sheet (annual, 2023-12-31) — Finished Goods: 302900000.00
BIO cash_flow (annual, 2023-12-31) — Free Cash Flow: 218200000.00
BIO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: -2500000.00
BIO income_statement (annual, 2023-12-31) — Gain On Sale Of Business: 2500000.00
BIO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -1244300000.00
BIO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -336000000.00
BIO balance_sheet (annual, 2023-12-31) — Goodwill: 413600000.00
BIO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 734100000.00
BIO balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 503900000.00
BIO balance_sheet (annual, 2023-12-31) — Gross PPE: 1790400000.00
BIO income_statement (annual, 2023-12-31) — Gross Profit: 1426900000.00
BIO income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
BIO income_statement (annual, 2023-12-31) — Interest Expense: 49400000.00
BIO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 49400000.00
BIO income_statement (annual, 2023-12-31) — Interest Income: 100900000.00
BIO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 100900000.00
BIO balance_sheet (annual, 2023-12-31) — Inventory: 780500000.00
BIO balance_sheet (annual, 2023-12-31) — Invested Capital: 9940800000.00
BIO cash_flow (annual, 2023-12-31) — Investing Cash Flow: 20200000.00
BIO balance_sheet (annual, 2023-12-31) — Investments And Advances: 7698100000.00
BIO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
BIO balance_sheet (annual, 2023-12-31) — Land And Improvements: 28400000.00
BIO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 165500000.00
BIO balance_sheet (annual, 2023-12-31) — Long Term Debt: 1199100000.00
BIO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 1364600000.00
BIO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
BIO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -500000.00
BIO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 2500000.00
BIO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -428700000.00
BIO balance_sheet (annual, 2023-12-31) — Net Debt: 795800000.00
BIO income_statement (annual, 2023-12-31) — Net Income: -637300000.00
BIO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -637300000.00
BIO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -637300000.00
BIO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -637300000.00
BIO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -637300000.00
BIO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -637300000.00
BIO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -637300000.00
BIO cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
BIO income_statement (annual, 2023-12-31) — Net Interest Income: 51500000.00
BIO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 174200000.00
BIO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -500000.00
BIO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -500000.00
BIO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 51500000.00
BIO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -14900000.00
BIO balance_sheet (annual, 2023-12-31) — Net PPE: 723700000.00
BIO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -156500000.00
BIO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 8007100000.00
BIO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 1475500000.00
BIO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 1475500000.00
BIO income_statement (annual, 2023-12-31) — Normalized EBITDA: 587000000.00
BIO income_statement (annual, 2023-12-31) — Normalized Income: 294050000.00
BIO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 374900000.00
BIO cash_flow (annual, 2023-12-31) — Operating Gains Losses: -2500000.00
BIO income_statement (annual, 2023-12-31) — Operating Income: 337800000.00
BIO income_statement (annual, 2023-12-31) — Operating Revenue: 2671200000.00
BIO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 28518436.00
BIO balance_sheet (annual, 2023-12-31) — Other Current Assets: 26100000.00
BIO balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 500000.00
BIO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 161600000.00
BIO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -336000000.00
BIO income_statement (annual, 2023-12-31) — Other Income Expense: -1239400000.00
BIO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 320500000.00
BIO balance_sheet (annual, 2023-12-31) — Other Inventories: 17000.00
BIO balance_sheet (annual, 2023-12-31) — Other Investments: 7698100000.00
BIO cash_flow (annual, 2023-12-31) — Other Non Cash Items: -12000000.00
BIO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 94900000.00
BIO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 195000000.00
BIO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 2400000.00
BIO balance_sheet (annual, 2023-12-31) — Other Properties: 1342200000.00
BIO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 1203300000.00
BIO income_statement (annual, 2023-12-31) — Other Special Charges: -2500000.00
BIO balance_sheet (annual, 2023-12-31) — Payables: 180400000.00
BIO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 320300000.00
BIO balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
BIO balance_sheet (annual, 2023-12-31) — Prepaid Assets: 140000000.00
BIO income_statement (annual, 2023-12-31) — Pretax Income: -850100000.00
BIO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 18500000.00
BIO balance_sheet (annual, 2023-12-31) — Properties: 0.00
BIO income_statement (annual, 2023-12-31) — Provision For Doubtful Accounts: 0.00
BIO cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 0.00
BIO cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
BIO cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
BIO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -689000000.00
BIO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -156700000.00
BIO balance_sheet (annual, 2023-12-31) — Raw Materials: 231600000.00
BIO balance_sheet (annual, 2023-12-31) — Receivables: 489000000.00
BIO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1244300000.00
BIO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 145900000.00
BIO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -500000.00
BIO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -428700000.00
BIO income_statement (annual, 2023-12-31) — Research And Development: 247400000.00
BIO balance_sheet (annual, 2023-12-31) — Restricted Cash: 5600000.00
BIO balance_sheet (annual, 2023-12-31) — Retained Earnings: 9260600000.00
BIO cash_flow (annual, 2023-12-31) — Sale Of Business: 2500000.00
BIO cash_flow (annual, 2023-12-31) — Sale Of Investment: 863200000.00
BIO cash_flow (annual, 2023-12-31) — Sale Of PPE: 200000.00
BIO income_statement (annual, 2023-12-31) — Selling General And Administration: 841700000.00
BIO balance_sheet (annual, 2023-12-31) — Share Issued: 30265874.00
BIO income_statement (annual, 2023-12-31) — Special Income Charges: 2500000.00
BIO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 61300000.00
BIO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 8741200000.00
BIO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 8007100000.00
BIO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -310450000.00
BIO income_statement (annual, 2023-12-31) — Tax Provision: -212800000.00
BIO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.25
BIO balance_sheet (annual, 2023-12-31) — Total Assets: 12299100000.00
BIO balance_sheet (annual, 2023-12-31) — Total Capitalization: 9940300000.00
BIO balance_sheet (annual, 2023-12-31) — Total Debt: 1405500000.00
BIO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 8741200000.00
BIO income_statement (annual, 2023-12-31) — Total Expenses: 2333400000.00
BIO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 3557900000.00
BIO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 9250800000.00
BIO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 3035100000.00
BIO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 337800000.00
BIO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 35800000.00
BIO income_statement (annual, 2023-12-31) — Total Unusual Items: -1241800000.00
BIO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -1241800000.00
BIO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 1747438.00
BIO balance_sheet (annual, 2023-12-31) — Treasury Stock: 632500000.00
BIO cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 1252300000.00
BIO balance_sheet (annual, 2023-12-31) — Work In Process: 246000000.00
BIO balance_sheet (annual, 2023-12-31) — Working Capital: 2525500000.00
BIO income_statement (annual, 2023-12-31) — Write Off: 0.00
BIO income_statement (quarterly, 2024-09-30) — Gain On Sale Of Business: 0.00
BIO cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: -3100000.00
BIO balance_sheet (quarterly, 2024-09-30) — Other Inventories: -24000.00
BIO balance_sheet (quarterly, 2024-09-30) — Restricted Cash: 5560000.00
BIO income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
BIO income_statement (annual, 2024-12-31) — +Operating Expense: 1109900000.00
BIO income_statement (annual, 2024-12-31) — +Total Revenue: 2566500000.00
BIO balance_sheet (annual, 2024-12-31) — Accounts Payable: 122300000.00
BIO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 452500000.00
BIO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1109200000.00
BIO balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -1109200000.00
BIO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 463200000.00
BIO balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -9200000.00
BIO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
BIO income_statement (annual, 2024-12-31) — Basic Average Shares: 28214000.00
BIO income_statement (annual, 2024-12-31) — Basic EPS: -65.36
BIO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 404400000.00
BIO balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 426300000.00
BIO balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 426300000.00
BIO cash_flow (annual, 2024-12-31) — Capital Expenditure: -189000000.00
BIO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 173100000.00
BIO balance_sheet (annual, 2024-12-31) — Capital Stock: 0.00
BIO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 488100000.00
BIO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1664500000.00
BIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -218800000.00
BIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -160200000.00
BIO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 455200000.00
BIO cash_flow (annual, 2024-12-31) — Change In Account Payable: -40900000.00
BIO cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: 24100000.00
BIO cash_flow (annual, 2024-12-31) — Change In Inventory: 8500000.00
BIO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -7500000.00
BIO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 5600000.00
BIO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -626800000.00
BIO cash_flow (annual, 2024-12-31) — Change In Payable: -16800000.00
BIO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -16800000.00
BIO cash_flow (annual, 2024-12-31) — Change In Receivables: 16200000.00
BIO cash_flow (annual, 2024-12-31) — Change In Tax Payable: 24100000.00
BIO cash_flow (annual, 2024-12-31) — Change In Working Capital: -620800000.00
BIO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 16200000.00
BIO cash_flow (annual, 2024-12-31) — Changes In Cash: 76200000.00
BIO balance_sheet (annual, 2024-12-31) — Common Stock: 0.00
BIO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 6569300000.00
BIO cash_flow (annual, 2024-12-31) — Common Stock Payments: -203600000.00
BIO income_statement (annual, 2024-12-31) — Cost Of Revenue: 1187600000.00
BIO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 124200000.00
BIO balance_sheet (annual, 2024-12-31) — Current Assets: 3030300000.00
BIO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 41700000.00
BIO balance_sheet (annual, 2024-12-31) — Current Debt: 1200000.00
BIO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 42900000.00
BIO balance_sheet (annual, 2024-12-31) — Current Liabilities: 467800000.00
BIO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 151600000.00
BIO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 151600000.00
BIO income_statement (annual, 2024-12-31) — Diluted Average Shares: 28214000.00
BIO income_statement (annual, 2024-12-31) — Diluted EPS: -65.36
BIO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -1844200000.00
BIO income_statement (annual, 2024-12-31) — EBIT: -2293600000.00
BIO income_statement (annual, 2024-12-31) — EBITDA: -2142000000.00
BIO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 9200000.00
BIO cash_flow (annual, 2024-12-31) — End Cash Position: 489800000.00
BIO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -218800000.00
BIO balance_sheet (annual, 2024-12-31) — Finished Goods: 294800000.00
BIO cash_flow (annual, 2024-12-31) — Free Cash Flow: 266200000.00
BIO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
BIO income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 0.00
BIO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Business: 0.00
BIO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -2646200000.00
BIO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -538200000.00
BIO balance_sheet (annual, 2024-12-31) — Goodwill: 410500000.00
BIO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 704100000.00
BIO balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 461700000.00
BIO balance_sheet (annual, 2024-12-31) — Gross PPE: 1797800000.00
BIO income_statement (annual, 2024-12-31) — Gross Profit: 1378900000.00
BIO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
BIO income_statement (annual, 2024-12-31) — Interest Expense: 48900000.00
BIO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 48900000.00